EB: Cadmium exposure tied to breast cancer progression

EB: Cadmium Exposure Tied to Breast Cancer Progression
EB: Cadmium Exposure Tied to Breast Cancer Progression

TUESDAY, April 24 (HealthDay News) -- Chronic cadmium exposure is associated with increased ability of breast cancer cells to migrate and invade through the extracellular matrix, as well as with increased expression of proteins associated with tumor invasion and metastasis, according to a study presented at the Experimental Biology 2012 meeting, held from April 21 to 25 in San Diego.

Noting that cadmium has been shown to increase the aggressive phenotype of mammary epithelial cells and to induce malignant transformation, Esmeralda M. Ponce, from the Dominican University of California in San Rafael, and colleagues investigated the impact of chronic cadmium exposure on breast cancer progression.

The researchers found that cadmium exposure was associated with an increase in the ability of MCF-7 cells to migrate and invade through the extracellular matrix. Higher levels of expression of SDF-1 (a protein associated with tumor invasion and metastasis) were seen in MCF-7 cells that were chronically exposed to cadmium. Significantly higher activity of matrix metalloproteinase-9 was seen in MCF-7 cells that were chronically exposed to cadmium.

"Understanding the role that cadmium plays in the progression of breast cancer is extremely important in order to find better ways to prevent the disease from advancing. Ninety percent of cancer deaths are associated with the cancer spreading to other parts of the body. If we can prevent the tumor from spreading, we have a better chance of treating cancer," a study coauthor said in a statement.

More Information

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs